Portugal vs South-East Asia (WHO region): Diabetes treatment coverage, age-standardized
Portugal
70.39
in 2022
South-East Asia (WHO region)
28.84
in 2022
Portugal rank
6th
South-East Asia (WHO region) rank
9th
Diabetes treatment coverage, age-standardized over time
- Portugal
- South-East Asia (WHO region)
How they compare
Portugal currently reports 70.39 against 28.84 in South-East Asia (WHO region), a difference of 41.55.
That makes Portugal's figure about 2.4 times South-East Asia (WHO region)'s.
Across all 33 years both countries report, Portugal has been ahead every year.
Portugal ranks 6th and South-East Asia (WHO region) ranks 9th of 198 countries.
Portugal has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Portugal | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 50.21 | 23.83 | 26.38 | Portugal |
| 2000s | 57.94 | 25.15 | 32.8 | Portugal |
| 2010s | 66.33 | 27.56 | 38.76 | Portugal |
| 2020s | 69.99 | 28.71 | 41.28 | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diabetes treatment coverage, age-standardized, Portugal or South-East Asia (WHO region)?
- Portugal, at 70.39 against 28.84 in South-East Asia (WHO region) as of 2022.
- What is the difference in diabetes treatment coverage, age-standardized between Portugal and South-East Asia (WHO region)?
- 41.55, with Portugal ahead.
- How many years of comparable data are there for Portugal and South-East Asia (WHO region)?
- 33 years are reported by both, from 1990 to 2022.
- How do Portugal and South-East Asia (WHO region) rank globally for diabetes treatment coverage, age-standardized?
- Portugal ranks 6th and South-East Asia (WHO region) ranks 9th of 198 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diabetes treatment coverage, age-standardized. Statizoid refreshes it automatically from the source and publishes the full history for both places.